2019
DOI: 10.1016/j.jtcvs.2019.06.034
|View full text |Cite
|
Sign up to set email alerts
|

Commentary: INSPIRE results? A critical appraisal of study end points

Abstract: Disclosures: Cypel is cofounder of Perfusix Canada, XOR Labs Toronto and consultant for lung bioengineering. Hoetzenecker has nothing to disclose with regard to commercial support.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 9 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?